<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02957643</url>
  </required_header>
  <id_info>
    <org_study_id>HippokratioGH</org_study_id>
    <nct_id>NCT02957643</nct_id>
  </id_info>
  <brief_title>Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hippocration General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hippocration General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the effectiveness of iron in the treatment of iron
      deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the
      hemoglobin, hematocrit and iron in serum and assess the course of treatment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaire</measure>
    <time_frame>up to 24 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Prevention of Anemia</condition>
  <arm_group>
    <arm_group_label>pregnant women</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>iron dosage 1 per day for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregnant women with low hemoglobin levels</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>iron dosage 1 per day for 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iron</intervention_name>
    <arm_group_label>pregnant women</arm_group_label>
    <arm_group_label>pregnant women with low hemoglobin levels</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age more or equal of 18 years

          2. Registration consent

          3. Have complete 12h week of pregnancy

          4. Hemoglobin levels &lt;10,5 ptl

          5. Hematocrit &lt; 32 %

        Exclusion Criteria:

          1. Age &lt;18 years

          2. Absent registration consent

          3. Step of pregnancy less than 12 weeks

          4. Coadministration formulations iron oral or parenterally

          5. Background of liver kirrosis

          6. Background of aimosidirosis

          7. Background acquired or chronic aimatochromatosis

          8. Aplastic , Hemolytic anemia and chronic diseases

          9. Chronic pancreatitis

         10. Subjective renal or/and liver disease

         11. Hypothyroidism or yperthyreoeidismos
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PANAGIOTIS MATSOUKATIDIS, MD,Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aristotle University of Thessaloniki School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>CHARALABOS KOLVATZIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aristotle University of Thessaloniki School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ANGELOS DANIILIDIS, Ass Prof</last_name>
    <phone>6932211395</phone>
    <phone_ext>0030</phone_ext>
    <email>ANGEDAN@HOTMAIL.COM</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>GEORGIOS CHOROZOGLOU, MD, Msc</last_name>
    <phone>00306942853182</phone>
    <email>gchorozoglou@gmail.com</email>
  </overall_contact_backup>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2016</study_first_submitted>
  <study_first_submitted_qc>November 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2016</study_first_posted>
  <last_update_submitted>November 3, 2016</last_update_submitted>
  <last_update_submitted_qc>November 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hippocration General Hospital</investigator_affiliation>
    <investigator_full_name>ANGELOS DANIILIDIS</investigator_full_name>
    <investigator_title>Assistant professor of obstetrics and gynaecology A.U.TH.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

